Stock DNA
Pharmaceuticals & Biotechnology
CNY 15,346 Million (Mid Cap)
88.00
NA
0.27%
-0.28
4.74%
4.49
Revenue and Profits:
Net Sales:
296 Million
(Quarterly Results - Mar 2026)
Net Profit:
43 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
129.31%
0%
129.31%
6 Months
182.29%
0%
182.29%
1 Year
161.24%
0%
161.24%
2 Years
131.68%
0%
131.68%
3 Years
8.67%
0%
8.67%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%
Wuxi Unicomp Technology Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
29.76%
EBIT Growth (5y)
-32.50%
EBIT to Interest (avg)
62.61
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.45
Sales to Capital Employed (avg)
0.24
Tax Ratio
12.65%
Dividend Payout Ratio
56.01%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
8.06%
ROE (avg)
3.01%
Valuation key factors
Factor
Value
P/E Ratio
88
Industry P/E
Price to Book Value
3.72
EV to EBIT
104.72
EV to EBITDA
85.09
EV to Capital Employed
5.61
EV to Sales
11.38
PEG Ratio
NA
Dividend Yield
0.34%
ROCE (Latest)
5.36%
ROE (Latest)
4.22%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
Bearish
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Bullish
Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY
Mar'26
Mar'25
Change(%)
Net Sales
295.90
199.50
48.32%
Operating Profit (PBDIT) excl Other Income
16.20
22.20
-27.03%
Interest
0.30
0.00
Exceptional Items
11.90
13.90
-14.39%
Consolidate Net Profit
42.90
34.90
22.92%
Operating Profit Margin (Excl OI)
54.70%
70.00%
-1.53%
USD in Million.
Net Sales
YoY Growth in quarter ended Mar 2026 is 48.32% vs 33.18% in Mar 2025
Consolidated Net Profit
YoY Growth in quarter ended Mar 2026 is 22.92% vs 3.25% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
1,072.60
736.40
45.65%
Operating Profit (PBDIT) excl Other Income
162.90
101.60
60.33%
Interest
3.10
0.50
520.00%
Exceptional Items
23.10
27.40
-15.69%
Consolidate Net Profit
173.70
143.30
21.21%
Operating Profit Margin (Excl OI)
112.40%
98.00%
1.44%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 45.65% vs 25.77% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 21.21% vs 25.48% in Dec 2024
About Wuxi Unicomp Technology Co., Ltd. 
Wuxi Unicomp Technology Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






